RankingsPricing
  1. JP-listed companies
  2. ASKA Pharmaceutical Holdings CO., Ltd.
  3. Income statement

ASKA Pharmaceutical Holdings CO., Ltd.【JP:4886】Income statement

Market cap
¥60.4B
P/E ratio
11.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Income statementBalance sheetCash flowOther
2022/032023/032024/032025/03
Revenue56,60760,46162,84364,139
Cost of revenue30,25531,87632,17832,803
Gross profit26,35128,58430,66431,335
Gross margin (%)
Operating income 4,7955,1086,5005,331
Operating expenses 21,55623,47624,16426,003
Income before tax 4,8805,2326,5225,107
Provision for income taxes1,8731,1182,3161,091
Net income 4,2904,2387,5455,101
Earnings per share151.22150.08266.51179.95
Dividend per share15164055
Raw aggregated data